- Tinea pedis:
- Apply to affected area BD until significant clinical improvement (no more than 4 weeks)
- Apply to affected area BD until significant clinical improvement (no more than 4 weeks)
- Tinea corporis & cruris:
- Apply OD *1/52 (no more than 4 weeks)
- Cream/Spray:
- 1% w/w
- Apply it as a thin layer on the clean and dry affected area
- Avoid contact with the nose, mouth or eyes
- Do not cover the affected areas with bandages or dressing after applying
Allylamine antifungal.
It inhibits squalene epoxidase thereby reducing fungal cell membrane ergosterol synthesis, a key component of fungal cell membranes.
- Irritation
- Burning
- Tingling
- Pruritus
- Hypersensitivity to class/components
- None remarkable
Drug Status
| Availability | Prescription only |
| Pregnancy | Can be used |
| Breastfeeding | Can be used |
| Schedule | Not scheduled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Dermafin | 1% w/w | Cream | 15g | Y.S.P. Industries | Y.S.P. Industries |
| Fungifin | 1% w/w | Cream | 15g | Universal Corporation | Universal Corporation |
| Fungiter | 1% w/w | Cream | 15g | Medistar Pharma | Medistar Pharma |
| Lamisil | 1% w/w | Cream | 15g | GSK Ltd | GSK Ltd |
| Mycofin | 1% w/v | Cream | 15g | Eskayef Ltd | Umoja Pharma |
| Oncosil | 1% w/w | Cream | 15g | Signature Healthcare | Signature Healthcare |
| Terbex | 1% w/w | Cream | 15g | Beximco Pharma | Madawa Pharma |
| Terbifin | 1% w/w | Cream | 15g | Cipla Ltd | Imperial Managed |
| Terbin | 1% w/w | Cream | 15g | Global Napi Pharma | Harley’s Ltd |
| Terbinol | 1% w/w | Cream | 15g | Dafra Pharm | Energia Pharm |
| Terbinol | 1% w/w | Spray | 30mL | Dafra Pharm | Energia Pharm |
| Terbisil | 1% w/w | Cream | 15g | Lords Healthcare | Lords Healthcare |
| Tfine | 1% w/w | Cream | 20g | Zawadi Healthcare | Zawadi Healthcare |